Cargando…

Differential diagnosis of thrombotic microangiopathy in nephrology

BACKGROUND: The differential diagnosis of thrombotic microangiopathy (TMA) is complex however the rapid diagnosis of the underlying condition is vital to inform urgent treatment decisions. A survey was devised with the objective of understanding current practices across Europe and the Middle East, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakari Jokiranta, T., Viklicky, Ondrej, Al Shorafa, Saleh, Coppo, Rosanna, Gasteyger, Christoph, Macia, Manuel, Pankratenko, Tatiana, Shenoy, Mohan, Soylemezoglu, Oğuz, Tsimaratos, Michel, Wetzels, Jack, Haller, Hermann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660444/ https://www.ncbi.nlm.nih.gov/pubmed/29080561 http://dx.doi.org/10.1186/s12882-017-0727-y

Ejemplares similares

Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
por: Grall, Maximilien, et al.
Publicado: (2021)

MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy
por: Petr, Vojtech, et al.
Publicado: (2022)

Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)

The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)

Thrombotic microangiopathy in children
por: Palma, Lilian Monteiro P., et al.
Publicado: (2022)

Rejection-associated Phenotype of De Novo Thrombotic Microangiopathy Represents a Risk for Premature Graft Loss
por: Petr, Vojtech, et al.
Publicado: (2021)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

Proteinuria Increases the PLASMIC and French Scores Performance to Predict Thrombotic Thrombocytopenic Purpura in Patients With Thrombotic Microangiopathy Syndrome
por: Fage, Nicolas, et al.
Publicado: (2021)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

Thrombotic microangiopathy in renal allografts
por: Radha, S., et al.
Publicado: (2014)

Influenza-associated thrombotic microangiopathies
por: Bitzan, Martin, et al.
Publicado: (2017)

Acyclovir-induced thrombotic microangiopathy
por: Goli, R., et al.
Publicado: (2017)

Cancer-associated thrombotic microangiopathy
por: Govind Babu, K, et al.
Publicado: (2016)

Complement in Secondary Thrombotic Microangiopathy
por: Palma, Lilian Monteiro Pereira, et al.
Publicado: (2020)

Thrombotic Microangiopathy Syndrome in the ICU
por: Samy Modeliar, S., et al.
Publicado: (2006)

Thrombotic Microangiopathy Syndrome in the ICU
por: Samy Modeliar, S., et al.
Publicado: (2006)

COVID-19 and thrombotic microangiopathies
por: Tiwari, Nishant R., et al.
Publicado: (2021)

Thrombotic microangiopathy triggered by podocytopathy
por: Veríssimo, Rita, et al.
Publicado: (2021)

Thrombotic microangiopathies: An illustrated review
por: Abou‐Ismail, Mouhamed Yazan, et al.
Publicado: (2022)

Diagnosis and treatment of thrombotic microangiopathy
por: Thompson, Gemma L., et al.
Publicado: (2022)

Chemotherapy-Associated Thrombotic Microangiopathy
por: Aklilu, Abinet M., et al.
Publicado: (2023)

Monoclonal gammopathy of renal significance presenting with cryoglobulinaemia type I associated severe thrombotic microangiopathy
por: Hesius, Eva, et al.
Publicado: (2022)

Thrombotic microangiopathy and associated renal disorders*
por: Barbour, Thomas, et al.
Publicado: (2012)

Thrombotic Microangiopathy in IgA Nephropathy
por: Nasri, Hamid
Publicado: (2013)

Thrombotic microangiopathy associated with proteasome inhibitors
por: Lodhi, Ahad, et al.
Publicado: (2015)

Cabozantinib‐induced renal thrombotic microangiopathy
por: La Manna, Gaetano, et al.
Publicado: (2017)

Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?
por: Hasbal, Nuri Baris
Publicado: (2020)

Eculizumab in chemotherapy-induced thrombotic microangiopathy
por: Schulte-Kemna, Lena, et al.
Publicado: (2020)

An Update in Drug-Induced Thrombotic Microangiopathy
por: Chatzikonstantinou, Thomas, et al.
Publicado: (2020)

Thrombotic microangiopathy in oncology – a review
por: Valério, Patrícia, et al.
Publicado: (2021)

Thrombotic microangiopathies assessment: mind the complement
por: Blasco, Miquel, et al.
Publicado: (2020)

Nintedanib-Induced Renal Thrombotic Microangiopathy
por: Fujita, Takeshi, et al.
Publicado: (2021)

Perindopril/amlodipine-induced thrombotic microangiopathy
por: Periša, Vlatka, et al.
Publicado: (2020)

Diagnostic Dilemma of Thrombotic Microangiopathy in Pregnancy
por: Kaartinen, Kati, et al.
Publicado: (2020)

Tacrolimus: Thrombotic microangiopathy: case report
Publicado: (2021)

Postsurgical Thrombotic Microangiopathy and Deregulated Complement
por: van Herpt, Thijs T. W., et al.
Publicado: (2022)

Thrombotic microangiopathy associated with lenvatinib therapy
por: Contreras Angulo, Macarena, et al.
Publicado: (2023)

Gemcitabine-Induced Renal Thrombotic Microangiopathy
por: Chaudhary, Ankur, et al.
Publicado: (2023)

Opana-induced thrombotic microangiopathy masquerading as thrombotic thrombocytopenic purpura
por: Ban, Byung H., et al.
Publicado: (2017)

Urine Protein/Creatinine Ratio in Thrombotic Microangiopathies: A Simple Test to Facilitate Thrombotic Thrombocytopenic Purpura and Hemolytic and Uremic Syndrome Diagnosis
por: Burguet, Laure, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ln05vbvagqsq9dqtdhhajnclfr